Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trialDongsheng Wang, Xiaoling Xu, Mingfeng Han et al.|Frontiers of Medicine|2021Cited by 80
Tocilizumab Ameliorates the Hypoxia in COVID-19 Moderate Patients with Bilateral Pulmonary Lesions: A Randomized, Controlled, Open-Label, Multicenter TrialDongsheng Wang, Xiaoling Xu, Binqing Fu et al.|SSRN Electronic Journal|2020Cited by 18